Finance

Lists
IGC:NYSEAMERICAN
IGC Pharma Inc
0,27 $
+1,81%
(+0,0049) 1D
0,27 $
-1,78% (-0,0049)
After hours
Closed: 2 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IGC...
Open
0,28 $
High
0,28 $
Low
0,27 $
Mkt. cap
28,42 млн
Avg. vol.
740,22 м.
Volume
607,91 м.
52-wk high
0,45 $
52-wk low
0,24 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
103,38 млн
No. of employees
70
Open
0,28 $
High
0,28 $
Low
0,27 $
Mkt. cap
28,42 млн
Avg. vol.
740,22 м.
Volume
607,91 м.
52-wk high
0,45 $
52-wk low
0,24 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
103,38 млн
No. of employees
70
News stories
From web sources and news partners
About IGC Pharma Inc
CEO-
Employees70
Founded2005
HeadquartersPotomac, Мэриленд, Америка Құрама Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024 ж. жел.
2025 ж. нау.
2026 ж. нау.
2026 ж. мау.
Revenue
257,00 м.
330,00 м.
317,00 м.
265,00 м.
Cost of goods sold
153,00 м.
176,00 м.
174,00 м.
217,00 м.
Cost of revenue
153,00 м.
176,00 м.
262,00 м.
217,00 м.
Research and development expenses
852,00 м.
997,00 м.
1,27 млн
1,59 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 млн
619,00 м.
1,20 млн
1,41 млн
Operating expense
1,98 млн
1,62 млн
2,51 млн
2,83 млн
Total operating expenses
2,14 млн
1,79 млн
2,78 млн
3,05 млн
Operating income
-1,88 млн
-1,46 млн
-2,46 млн
-2,78 млн
Other non operating income
49,00 мың
190,00 м.
56,00 мың
1,08 млн
EBT including unusual items
-1,83 млн
-1,20 млн
-1,60 млн
-2,94 млн
EBT excluding unusual items
-1,83 млн
-1,27 млн
-1,60 млн
-2,94 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,83 млн
-1,20 млн
-2,40 млн
-1,82 млн
Net profit margin
-711,67%
-362,73%
-757,73%
-1 107,92%
Earnings per share
-0,02
-0,01
-0,02
-0,03
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,72 млн
-1,31 млн
-2,40 млн
-2,73 млн
Gain or loss from assets sale
-
-25,00 мың
-
-
AI content may include mistakes. Learn more
Google қолданбалары